Gene: SLC39A10

57181
LZT-Hs2
solute carrier family 39 member 10
protein-coding
2q32.3
Ensembl:ENSG00000196950 MIM:608733 Vega:OTTHUMG00000154380 UniprotKB:Q9ULF5
NC_000002.12
PubMed|SNP Mapped
8   ANCO-SNPs
AD
1   
7.508e-2 (AD)  6.592e-1 (ND)   (Frontal_Cortex)
4.270e-2 (AD)  2.140e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs6756374chr2:195722946 (GRCh38.p7)C>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs6706771chr2:195700517 (GRCh38.p7)G>A / G>Talcohol dependenceSNV(Single Nucleotide Variation)
rs1561451chr2:195684712 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs10178320chr2:195677278 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs1866452chr2:195671781 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs7424415chr2:195671426 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs11682521chr2:195652785 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs10460389chr2:195641240 (GRCh38.p7)C>Aalcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SCN2A0.961
MAPK90.961
CDK140.96
ADAM220.96
KIF3A0.958
GSK3B0.958
OLFM30.956
TRIM370.956
SYNJ10.956
CREG20.954

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
TGIF1-0.522
CSAG1-0.522
RAB13-0.518
CNN2-0.508
HEY2-0.505
RHOD-0.503
RNF135-0.501
AGTRAP-0.495
EVC2-0.494
EMP3-0.491

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC39A10 mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC39A10 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC39A10 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC39A10 mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC39A10 mRNA"25510870
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of SLC39A10 mRNA29067470
D016604Aflatoxin B1Aflatoxin B1 affects the expression of SLC39A10 protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of SLC39A10 mRNA27153756
C006632arsenic trioxidearsenic trioxide results in decreased expression of SLC39A10 mRNA27829220
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of SLC39A10 mRNA20106945
D004958EstradiolEstradiol results in decreased expression of SLC39A10 mRNA20106945|2163298
C044887beta-methylcholinebeta-methylcholine affects the expression of SLC39A10 mRNA21179406
C006780bisphenol Abisphenol A results in decreased expression of SLC39A10 mRNA29275510
C006780bisphenol Abisphenol A results in decreased expression of SLC39A10 mRNA26063408
C006780bisphenol Abisphenol A affects the expression of SLC39A10 mRNA21786754
C006780bisphenol A[bisphenol A co-treated with Testosterone] results in increased expression of SLC39A10 mRNA26496021
C006780bisphenol Abisphenol A results in decreased expression of SLC39A10 mRNA25181051
C584509C646 compoundC646 compound results in decreased expression of SLC39A10 mRNA26191083
D002104Cadmium[Cadmium co-treated with Zinc] results in increased expression of SLC39A10 mRNA21756885
D002104CadmiumCadmium results in increased expression of SLC39A10 mRNA21756885
D002104CadmiumCadmium inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D019256Cadmium ChlorideCadmium Chloride affects the expression of SLC39A10 mRNA22110744
C037123cadmium sulfatecadmium sulfate affects the reaction [MTF1 affects the expression of SLC39A10 mRNA]16221973
D002185CannabidiolCannabidiol results in decreased expression of SLC39A10 mRNA21542829|2217845
D002220CarbamazepineCarbamazepine affects the expression of SLC39A10 mRNA25979313
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC39A10 mRNA23650126
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in decreased expression of SLC39A10 mRNA26272509
C018021cobaltous chloridecobaltous chloride results in decreased expression of SLC39A10 mRNA24386269
D003042CocaineCocaine results in decreased expression of SLC39A10 mRNA17898221
D016572CyclosporineCyclosporine results in decreased expression of SLC39A10 mRNA20106945|2490755
D003609Dactinomycin"Dactinomycin inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA]"21738690
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of SLC39A10 mRNA]27941970
D002945CisplatinCisplatin results in decreased expression of SLC39A10 mRNA27594783
C000944dicrotophosdicrotophos results in decreased expression of SLC39A10 mRNA28302478
D004024DicyclohexylcarbodiimideDicyclohexylcarbodiimide inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D004041Dietary FatsDietary Fats results in increased expression of SLC39A10 mRNA18042831|1903023
D004041Dietary Fatsrimonabant inhibits the reaction [Dietary Fats results in increased expression of SLC39A10 mRNA]19030233
D002117CalcitriolCalcitriol results in decreased expression of SLC39A10 mRNA20089671
D0198131,2-Dimethylhydrazine"[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SLC39A10 mRNA"27840820
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLC39A10 protein23301498
C045651epigallocatechin gallate[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC39A10 mRNA22079256
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in decreased expression of SLC39A10 mRNA23649840
C061365flusilazoleflusilazole results in decreased expression of SLC39A10 mRNA28263823
C064925gadodiamidegadodiamide results in increased expression of SLC39A10 mRNA20959327
D005839GentamicinsGentamicins results in increased expression of SLC39A10 mRNA22061828
D005947Glucose[INS protein co-treated with Glucose] results in decreased expression of SLC39A10 mRNA22634610
C511402Grape Seed ProanthocyanidinsGrape Seed Proanthocyanidins results in increased expression of SLC39A10 mRNA20471814
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of SLC39A10 mRNA20044591
D007461IodoacetatesIodoacetates inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SLC39A10 mRNA25613284
C544151jinfukangjinfukang results in decreased expression of SLC39A10 mRNA27392435
C008261lead acetatelead acetate results in decreased expression of SLC39A10 mRNA25270620
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in increased expression of SLC39A10 mRNA"24972896
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of SLC39A10 mRNA17126599
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of SLC39A10 protein16892068
D008070LipopolysaccharidesTICAM1 protein affects the reaction [Lipopolysaccharides results in decreased expression of SLC39A10 protein]16892068
D008623MercaptoethanolMercaptoethanol inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D008727MethotrexateMethotrexate affects the expression of SLC39A10 mRNA18502557
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of SLC39A10 mRNA23649840
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC39A10 mRNA"26251327
C437683motexafin gadoliniummotexafin gadolinium affects the expression of SLC39A10 mRNA16357179
C437683motexafin gadolinium[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A10 mRNA16357179
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of SLC39A10 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of SLC39A10 mRNA"25554681
C461488N-benzylpiperazineN-benzylpiperazine results in increased expression of SLC39A10 mRNA26821219
C022838nickel chloridenickel chloride affects the expression of SLC39A10 mRNA22110744
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc] results in decreased expression of SLC39A10 mRNA"19720134
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mRNA"19720134
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"[Zinc co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mRNA"19720134
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"Dactinomycin inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA]"21738690
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [MTF1 protein binds to SLC39A10 promoter]"21738690
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA"21738690
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 protein"21738690
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA]"21738690
C558013NSC 689534NSC 689534 results in increased expression of SLC39A10 mRNA20971185
C025589ochratoxin A"[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc] results in decreased expression of SLC39A10 mRNA"19720134
C025589ochratoxin A"[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mRNA"19720134
D000073878Palm OilPalm Oil results in increased expression of SLC39A10 mRNA18042831
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC39A10 mRNA"25510870
C568608PCI 5002[PCI 5002 co-treated with Zinc] results in increased expression of SLC39A10 mRNA18593933
D004369Pentetic AcidPentetic Acid results in increased expression of SLC39A10 mRNA21738690
D004369Pentetic AcidPentetic Acid results in increased expression of SLC39A10 protein21738690
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of SLC39A10 mRNA27153767
D010634PhenobarbitalPhenobarbital affects the expression of SLC39A10 mRNA23091169
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A10 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in decreased expression of SLC39A10 mRNA26272509
C027373potassium chromate(VI)[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC39A10 mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of SLC39A10 mRNA22079256
D011374ProgesteroneProgesterone results in increased expression of SLC39A10 mRNA23012394
D011794QuercetinQuercetin results in increased expression of SLC39A10 mRNA21632981
C089032rimonabantrimonabant inhibits the reaction [Dietary Fats results in increased expression of SLC39A10 mRNA]19030233
D012822Silicon DioxideSilicon Dioxide analog results in increased expression of SLC39A10 mRNA25895662
D012834SilverSilver results in decreased expression of SLC39A10 mRNA26014281
D013739Testosterone[bisphenol A co-treated with Testosterone] results in increased expression of SLC39A10 mRNA26496021
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of SLC39A10 mRNA20106945
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of SLC39A10 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of SLC39A10 mRNA21354282
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of SLC39A10 mRNA21215274
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SLC39A10 mRNA25613284
D013853ThioacetamideThioacetamide results in increased expression of SLC39A10 mRNA23411599
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of SLC39A10 mRNA"26179874
C406224valdecoxibvaldecoxib results in increased expression of SLC39A10 mRNA24136188
D014635Valproic AcidValproic Acid affects the expression of SLC39A10 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of SLC39A10 mRNA23179753
D014635Valproic AcidValproic Acid results in decreased methylation of SLC39A10 gene29154799
D014635Valproic AcidValproic Acid affects the expression of SLC39A10 mRNA17292431
D001335Vehicle EmissionsVehicle Emissions affects the methylation of SLC39A10 gene25560391
D015215ZidovudineZidovudine results in decreased expression of SLC39A10 mRNA24292225
D015032Zinc[Cadmium co-treated with Zinc] results in increased expression of SLC39A10 mRNA21756885
D015032Zinc"[ochratoxin A co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc] results in decreased expression of SLC39A10 mRNA"19720134
D015032Zinc[PCI 5002 co-treated with Zinc] results in increased expression of SLC39A10 mRNA18593933
D015032ZincSLC39A10 protein results in increased transport of Zinc18326752
D015032Zinc"[Zinc co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SLC39A10 mRNA"19720134
D015032ZincMTF1 mutant form inhibits the reaction [Zinc results in decreased expression of SLC39A10 mRNA]21738690
D015032ZincZinc deficiency results in increased expression of SLC39A10 mRNA21738690
D015032ZincZinc deficiency results in increased expression of SLC39A10 protein18936201|2173869
D015032Zinc"Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A10 mRNA]"21738690
D015032ZincZinc inhibits the reaction [Zinc deficiency results in increased expression of SLC39A10 mRNA]21738690
D015032ZincZinc inhibits the reaction [Zinc deficiency results in increased expression of SLC39A10 protein]21738690
D015032ZincZinc promotes the reaction [MTF1 protein binds to SLC39A10 promoter]21738690
D015032ZincZinc results in decreased expression of SLC39A10 mRNA21738690
D015032ZincCadmium inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D015032ZincDicyclohexylcarbodiimide inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D015032ZincIodoacetates inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D015032ZincMercaptoethanol inhibits the reaction [SLC39A10 protein results in increased uptake of Zinc]16804107
D015032ZincSLC39A10 protein results in increased uptake of Zinc16804107
D015032ZincZinc results in decreased expression of SLC39A10 mRNA16804107
D015032ZincZinc results in decreased expression of SLC39A10 protein16804107
D015032ZincZinc results in increased expression of SLC39A10 mRNA16804107
D015032ZincZinc results in increased expression of SLC39A10 protein16804107
D015032ZincZinc results in decreased expression of SLC39A10 mRNA16804107
D015032ZincZinc results in increased expression of SLC39A10 mRNA16804107
D015032ZincSLC39A10 protein results in increased uptake of Zinc17126599
D019345Zinc AcetateZinc Acetate affects the expression of SLC39A10 mRNA16357179
D019345Zinc Acetate[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A10 mRNA16357179
D019287Zinc SulfateZinc Sulfate results in decreased expression of SLC39A10 mRNA16804107
D019287Zinc SulfateZinc Sulfate results in decreased expression of SLC39A10 protein16804107
D019287Zinc SulfateZinc Sulfate results in increased expression of SLC39A10 mRNA16804107
D019287Zinc SulfateZinc Sulfate results in increased expression of SLC39A10 protein16804107
D019287Zinc SulfateZinc Sulfate results in decreased expression of SLC39A10 mRNA16804107
D019287Zinc SulfateZinc Sulfate results in increased expression of SLC39A10 mRNA16804107
C088658zoledronic acidzoledronic acid results in decreased expression of SLC39A10 mRNA24714768

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005385zinc ion transmembrane transporter activity-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0002903negative regulation of B cell apoptotic process-IEA-  
GO:0006882cellular zinc ion homeostasis-IBA21873635  
GO:0030890positive regulation of B cell proliferation-IEA-  
GO:0050861positive regulation of B cell receptor signaling pathway-IBA21873635  
GO:0071578zinc ion import across plasma membrane-IBA21873635  
GO:1903615positive regulation of protein tyrosine phosphatase activity-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005887integral component of plasma membrane-IBA21873635  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-382551Transport of small moleculesIEA
R-HSA-425366Transport of bile salts and organic acids, metal ions and amine compoundsIEA
R-HSA-425407SLC-mediated transmembrane transportIEA
R-HSA-425410Metal ion SLC transportersIEA
R-HSA-435354Zinc transportersIEA
R-HSA-442380Zinc influx into cells by the SLC39 gene familyIEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
23981442Stress-response pathways are altered in the hippocampus of chronic alcoholics. (2013 Nov)McClintick JNAlcohol